xCella Biosciences Competitors and Similar CompaniesClear all

Puma Biotechnology's competitors and similar companies include Replimune and Immuneering.
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Replimune
Replimune
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
Immuneering
Immuneering
Immuneering is a biopharmaceutical company that develops medicines for the treatment of a spectrum of oncologic diseases.
Founding Date
Founding Date
2010
Founding Date
2015
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Los Angeles, US HQ
Locations
Woburn, US HQ
Milton, GB
Woburn, US
Locations
Cambridge, US HQ
New York, US
San Diego, US
Employees
Employees
27214% decrease
Employees
10422% increase
Employees
5320% decrease
Valuation ($)
Valuation ($)
136.8 m
Valuation ($)
823.3 m
Valuation ($)
58.7 m

Financial

Net income
Net income
N/A
Net income
($313.9m) (FY, 2026)
Net income
($56m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 172m
Total funding raised
$ 30m
Total funding raised
$ 57.2m
For sources of this data, please see the company profile

View Company Profiles

Replimune
HQ
Woburn, US
Employees
104↑ 22% increase

Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.

View company
Immuneering
HQ
Cambridge, US
Employees
53↓ 20% decrease

Immuneering is a biopharmaceutical company that develops medicines for the treatment of a spectrum of oncologic diseases.

View company